Point72 Middle East FZE’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-5,465
Closed -$310K 760
2023
Q4
$310K Buy
5,465
+685
+14% +$35.9K 0.01% 949
2023
Q3
$260K Buy
+4,780
New +$283K 0.01% 962

Other funds holding LMAT

Point72 Middle East FZE's LMAT Position: Q1 2024 in Review

Point72 Middle East FZE sold out of LeMaitre Vascular (LMAT) in Q1 2024, closing a stake of 5,465 shares — an estimated $310K sold.

Point72 Middle East FZE first reported a position in LMAT in Q3 2023 and held it in 2 quarters. The position peaked at $310K in Q4 2023. 243 funds tracked by Wall St. Rank hold LMAT as of Q1 2024.

  • Point72 Middle East FZE reported no remaining LeMaitre Vascular position as of Q1 2024 after selling out during the quarter.
  • Point72 Middle East FZE sold 5,465 LeMaitre Vascular shares in Q1 2024, an estimated $310K.
  • Point72 Middle East FZE first reported a position in LeMaitre Vascular in Q3 2023 and held it in 2 quarters.
  • Point72 Middle East FZE's LeMaitre Vascular position peaked at $310K in Q4 2023.
  • 243 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2024.

Based on Point72 Middle East FZE's 13F filing for Q1 2024.